Artificial muscle power
ABOVE: University of Delaware researchers are developing a medical device to help children with cerebral palsy. The device includes a novel artificial muscle that can assist when a child’s own muscle power isn’t enough to complete a movement. From left to right are Joy Goswami, Elisa Arch, Martha Hall, Samuel Lee, Ahad Behboodi and Prabhpreet Gill. | Photos by Kathy F. Atkinson
UD research team funded to develop medical device for children with cerebral palsy
Think about the way your leg muscles work. At rest, the muscles are relaxed and stretched out. When in use, the muscles tighten to perform any number of movements, from lifting your foot to walking, dancing and more.
For children with cerebral palsy — a lifelong condition characterized by joint stiffness, jerky movements and muscle tightness — these motions can be taxing, sometimes impossible.
Cerebral palsy (CP) is the most common motor disorder in pediatric populations. One in 323 children in the United States is diagnosed with CP, with the majority needing multiple devices over their lifetime to improve their mobility, according to the Cerebral Palsy Alliance Research Foundation.
Now, a University of Delaware team of researchers from the College of Health Sciences has received nearly $200,000 in start-up funding, through a QED grant from the University City Science Center in Philadelphia, to develop a motorized ankle foot device for children with CP that includes a novel artificial muscle.
UD Research on Twitter
Biopharmaceuticals have emerged recently and are having a revolutionary impact on vexing diseases such as cancer. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered at the University of Delaware, is at the forefront of making medicines more accessible to Americans.
Rhonda Prisby had a plan for her master’s degree in exercise physiology. She expected to work in a cardiac rehabilitation clinic. Then a professor mentioned something she hadn’t considered—her potential as a researcher.